Jeff Boyd, Ph.D., a renowned expert in cancer research and genetic testing, joins the executive leadership of Miami Cancer Institute at Baptist Health South Florida as director of translational research and genomic medicine.
In this capacity, Dr. Boyd will play a critical role in positioning Miami Cancer Institute’s Center for Genomic Medicine as an international leader for highly personalized genetic analyses tailored to patients’ individual needs.
Dr. Boyd was most recently senior vice president for Molecular Medicine, executive director of the Cancer Genome Institute and the Robert C. Young, M.D., Chair in Cancer Research at Fox Chase Cancer Center in Philadelphia, where he also maintained a research laboratory.
Previously, he served as attending biologist and director of the Diagnostic Molecular Genetics Laboratory and the Gynecology and Breast Research Laboratory at Memorial Sloan-Kettering Cancer Center in New York.
Dr. Boyd is professor and chairman of the Department of Human and Molecular Genetics at Florida International University’s Herbert Wertheim College of Medicine. He serves on the editorial board of the American Journal of Pathology and has held faculty positions at Memorial Sloan-Kettering Cancer Center, the University of Pennsylvania and the National Institutes of Health.